Nathan Rice
Stock Analyst at Piper Sandler
(3.08)
# 1,185
Out of 5,163 analysts
61
Total ratings
52.63%
Success rate
10.62%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFC Bank First | Maintains: Neutral | $142 → $150 | $135.44 | +10.75% | 10 | Jan 26, 2026 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $39.40 | +21.83% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $41.66 | +0.82% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $30.50 | +14.75% | 9 | Oct 28, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $76.13 | -2.80% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $149.21 | -43.70% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $164.23 | +19.95% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $22.94 | -60.77% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $573.82 | -24.19% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $267.19 | -12.80% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $34.45 | +140.93% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $19.48 | -23.00% | 1 | Dec 19, 2019 |
Bank First
Jan 26, 2026
Maintains: Neutral
Price Target: $142 → $150
Current: $135.44
Upside: +10.75%
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $39.40
Upside: +21.83%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $41.66
Upside: +0.82%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $30.50
Upside: +14.75%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $76.13
Upside: -2.80%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $149.21
Upside: -43.70%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $164.23
Upside: +19.95%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $22.94
Upside: -60.77%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $573.82
Upside: -24.19%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $267.19
Upside: -12.80%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $34.45
Upside: +140.93%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $19.48
Upside: -23.00%